Top Markets
Coin of the day
PRF Technologies Ltd. PRF Technologies Ltd.

PRF Technologies Ltd.

PRFX
Classifica tra le azioni #40770
PRF Technologies Ltd. operates as a specialized pharmaceutical company,... PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Prezzo delle azioni
$1.04
Capitalizzazione di mercato
$83.35K
Variazione (1 giorno)
0.49%
Variazione (1 anno)
-85.72%
Paese
IL
Scambia PRF Technologies Ltd. (PRFX)

Categoria

EPS per PRF Technologies Ltd. (PRFX)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PRF Technologies Ltd., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per PRF Technologies Ltd. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti